Top and Current
Source: (remove) : David Amsellem
RSSJSONXMLCSV
Top and Current
Source: (remove) : David Amsellem
RSSJSONXMLCSV
Wed, September 11, 2024
Thu, August 8, 2024
Fri, August 2, 2024
Thu, June 27, 2024
Mon, May 13, 2024
Fri, May 10, 2024
Thu, April 11, 2024
Mon, April 1, 2024
Thu, March 28, 2024
Thu, March 21, 2024
Tue, March 5, 2024
Wed, February 28, 2024
Fri, February 16, 2024
Mon, February 12, 2024
Tue, January 16, 2024
Wed, January 3, 2024
Wed, November 22, 2023
Tue, November 14, 2023
Fri, November 10, 2023
Thu, November 9, 2023
Fri, October 27, 2023
Wed, October 25, 2023
Thu, August 10, 2023
Tue, August 8, 2023
Mon, August 7, 2023
Wed, June 7, 2023
Wed, May 10, 2023
Mon, May 8, 2023
Tue, March 7, 2023
Mon, January 23, 2023
Thu, January 5, 2023
Wed, November 23, 2022
Tue, November 8, 2022
Thu, November 3, 2022
Tue, October 25, 2022
Fri, September 9, 2022
Wed, August 31, 2022
Tue, August 16, 2022
Tue, May 10, 2022
Wed, May 4, 2022
Wed, March 16, 2022
Fri, March 11, 2022
Fri, January 7, 2022
Thu, November 5, 2020
Wed, August 19, 2020
Tue, June 16, 2020
Mon, May 4, 2020
Wed, April 15, 2020
Wed, February 26, 2020
Tue, February 18, 2020
Mon, December 30, 2019
Fri, November 8, 2019
Wed, January 23, 2019
Wed, January 2, 2019
Thu, September 13, 2018
Fri, February 9, 2018
Mon, July 17, 2017
Thu, June 1, 2017
Mon, July 18, 2016
Thu, June 18, 2015
Mon, July 21, 2014
Tue, May 14, 2013
Fri, March 15, 2013
Mon, August 13, 2012

David Amsellem Downgraded (SUPN) to Hold and Decreased Target to $36 on, Sep 11th, 2024


Published on 2024-10-28 14:11:43 - WOPRAI, David Amsellem
  Print publication without navigation


David Amsellem of Piper Sandler, Downgraded "Supernus Pharmaceuticals, Inc." (SUPN) to Hold and Decreased Target from $41 to $36 on, Sep 11th, 2024.

David, nor any peers, have made any analyst calls on SUPN in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30